https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-26 / Cancers (Basel) 2018 Sep;10(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-26 / Cancers (Basel) 2018 Sep;10(10)2018-09-26 00:00:002018-09-26 00:00:00The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-1638
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-16382018-09-11 00:00:002018-09-11 00:00:00Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-08-25 / Curr Oncol Rep 2018 08;20(10):80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-08-25 / Curr Oncol Rep 2018 08;20(10):802018-08-25 00:00:002018-08-25 00:00:00The Role of Oncolytic Viruses in the Treatment of Melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-08-01 / Am J Cancer Res 2018;8(8):1514-1527
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-08-01 / Am J Cancer Res 2018;8(8):1514-15272018-08-01 00:00:002018-08-01 00:00:00Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-08-01 / Nat. Rev. Immunol. 2018 Aug;18(8):498-513
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-08-01 / Nat. Rev. Immunol. 2018 Aug;18(8):498-5132018-08-01 00:00:002019-02-15 09:23:18Integrating oncolytic viruses in combination cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-31 / Sci Rep 2018 Jul;8(1):11470
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-31 / Sci Rep 2018 Jul;8(1):114702018-07-31 00:00:002019-02-15 09:00:24Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-18 / BMC Cancer 2018 Jul;18(1):746
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-18 / BMC Cancer 2018 Jul;18(1):7462018-07-18 00:00:002018-07-18 00:00:00Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):194-196
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):194-1962018-06-26 00:00:002019-02-15 09:23:06Exploiting Viruses to Treat Diseases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):150-161
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):150-1612018-06-26 00:00:002019-02-15 09:00:21Recurrent Glioblastoma Treated with Recombinant Poliovirus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-19 / Oncotarget 2018 Jun;9(47):28702-28716
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-19 / Oncotarget 2018 Jun;9(47):28702-287162018-06-19 00:00:002019-02-15 08:36:18Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
